BOCA RATON, Fla.--( BUSINESS WIRE )-- TherapeuticsMD, Inc. (NYSE MKT: TXMD) announced today the pricing of an underwritten offering of 13,750,000 shares of its common stock, offered at a price of $2.40 per share. The gross proceeds to TherapeuticsMD from this offering are expected to be approximately $33 million, before deducting underwriting discounts, commissions, and other estimated offering expenses payable by TherapeuticsMD. All of the shares in the offering are to be sold by TherapeuticsMD. The offering is expected to close on or about September 30, 2013, subject to the satisfaction of customary closing conditions.